ENDONOVO THERAPEUTICS, INC. Derivative Liability
ENDONOVO THERAPEUTICS, INC. (ENDV) had Derivative Liability of $5.90 million as of 2023-09-30, per its 10-Q filed 2023-12-29.
Discontinued › Balance Sheet › Liabilities
us-gaap:DerivativeLiabilities · last filed 2023-12-29
- 2023-09-30: Derivative Liability $5.90M.
- 2023-06-30: Derivative Liability $5.90M.
- 2023-03-31: Derivative Liability $9.32M.
- 2022-09-30: Derivative Liability $5.24M.
| Period end | Derivative Liability |
|---|---|
| 2023-09-30 | $5.90M 10-Q · filed 2023-12-29 |
| 2023-06-30 | $5.90M 10-Q · filed 2023-08-21 |
| 2023-03-31 | $9.32M 10-Q · filed 2023-05-22 |
| 2022-09-30 | $5.24M 10-Q · filed 2022-11-21 |
| 2022-06-30 | $5.29M 10-Q · filed 2022-08-22 |
| 2022-03-31 | $4.97M 10-Q · filed 2022-05-19 |
| 2021-12-31 | $3.44M 10-K · filed 2022-04-14 |
| 2021-09-30 | $6.45M 10-Q · filed 2021-11-19 |
| 2021-06-30 | $5.90M 10-Q · filed 2021-08-23 |
| 2021-03-31 | $5.29M 10-Q · filed 2021-05-24 |
| 2020-12-31 | $4.20M 10-K · filed 2022-04-14 |
| 2020-09-30 | $3.46M 10-Q · filed 2020-11-19 |
| 2020-06-30 | $3.67M 10-Q · filed 2020-08-19 |
| 2020-03-31 | $3.17M 10-Q · filed 2020-06-12 |
| 2019-12-31 | $10.60M 10-K · filed 2021-04-13 |
| 2019-09-30 | $7.07M 10-Q · filed 2019-11-19 |
| 2019-06-30 | $8.17M 10-Q · filed 2019-08-13 |
| 2019-03-31 | $3.87M 10-Q · filed 2019-05-09 |
| 2018-12-31 | $4.43M 10-K · filed 2020-05-04 |
| 2018-09-30 | $7.06M 10-Q · filed 2018-11-13 |
| 2018-06-30 | $3.12M 10-Q · filed 2018-08-13 |
| 2018-03-31 | $3.82M 10-Q · filed 2018-05-18 |
| 2017-12-31 | $5.94M 10-K · filed 2019-04-15 |
| 2017-09-30 | $7.22M 10-Q/A · filed 2017-11-09 |
| 2017-06-30 | $2.14M 10-Q · filed 2017-08-10 |
| 2017-03-31 | $6.57M 10-Q · filed 2017-05-12 |
| 2016-12-31 | $1.93M 10-K · filed 2018-04-06 |
| 2016-09-30 | $2.18M 10-Q · filed 2016-11-14 |
| 2016-06-30 | $1.17M 10-Q · filed 2016-08-12 |
| 2015-12-31 | $3.97M 10-K · filed 2017-04-17 |